Small interfering RNA targeting ACVR1c and uses thereof
TW202635886APending Publication Date: 2026-09-01SANEGENE BIO USA INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW115103236
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-01-27
- Filing Date
- 2026-01-27
- Publication Date
- 2026-09-01
Smart Images
Figure TWG2TA001075214_001 
Figure TWG2TA001075214_002 
Figure TWG2TA001075214_003
Abstract
This disclosure relates to isolated oligonucleotides comprising duplex regions targeting human ACVR1C mRNA, and delivery systems, kits and compositions comprising the same, and methods of using the same for inhibiting or downregulating ACVR1C gene expression and treating or preventing a disease or disorder associated with aberrant or increased expression or activity of ACVR1C, or a disease or disorder where ACVR1C plays a role.
Need to check novelty before this filing date? Find Prior Art